{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T11:58:54Z","timestamp":1765886334603,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T00:00:00Z","timestamp":1658188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2021YFC0863300"],"award-info":[{"award-number":["2021YFC0863300"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Although the FDA has given emergency use authorization (EUA) for some antiviral drugs for the treatment of COVID-19, no direct antiviral drugs have been identified for the treatment of critically ill patients, the most important treatment is suppression of the hyperinflammation. The purpose of this study was to evaluate the role of corticosteroids in hospitalized severe or critical patients positive for COVID-19. This is a retrospective single-center descriptive study. Patients classified as having severe or critical COVID-19 infections with acute respiratory dysfunction syndrome in Shenzhen Third People\u2019s Hospital were enrolled from January 11th to March 30th, 2020. Ninety patients were classified as having severe or critical COVID-19 infections. The patients were treated with methylprednisolone with a low-to-moderate dosage and short duration. The days from the symptom onset to methylprednisolone were about 8 days. Eighteen patients were treated with invasive ventilation and intensive care unit (ICU) care. All the patients in the severe group and ten in the critical group recovered and were discharged. Three critical cases with invasive ventilation died. Although cases were much more severe in the corticosteroid-treated group, the mortality was not significantly increased. Early use of low-to-moderate dosage and short duration of corticosteroid may be the more accurate immune-modulatory treatment and brings more benefits to severe patients with COVID-19.<\/jats:p>","DOI":"10.3389\/fmicb.2022.953328","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T07:12:03Z","timestamp":1658214723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Low-to-Moderate Dosage and Short-Term Use of Corticosteroids Benefit Patients With Severe COVID-19 Infections"],"prefix":"10.3389","volume":"13","author":[{"given":"Liuqing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengli","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer St.","family":"Sauver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: the REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. China: a descriptive study.","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: a Randomized Clinical Trial.","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/cid\/ciaa601","article-title":"Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19.","volume":"71","author":"Fadel","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with Covid-19.","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric Preprocessing for Parametric Causal Inference.","volume":"42","author":"Ho","year":"2011","journal-title":"J. Stat. Softw."},{"key":"B8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan.","volume":"395","author":"Huang","year":"2020","journal-title":"China. Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): a Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.","volume":"72","author":"Jeronimo","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1671-0282.2020.02.0011","article-title":"The possibility of using Lopinave\/Litonawe (LPV\/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies.","volume":"29","author":"Jiang Hua","year":"2020","journal-title":"Chin. J. Emerg. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1086\/424016","article-title":"Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study.","volume":"39","author":"Lee","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients.","volume":"31","author":"Lee","year":"","journal-title":"J. Clin. Virol."},{"key":"B13","first-page":"1348","article-title":"[Factors of avascular necrosis of femoral head and osteoporosis in SARS patients\u2019 convalescence].","volume":"84","author":"Li","year":"2004","journal-title":"Zhonghua Xue Za Zhi"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-02964-w","article-title":"Adjuvant corticosteroid therapy for critically ill patients with COVID-19.","volume":"24","author":"Lu","year":"2020","journal-title":"Crit. Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression.","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","article-title":"On the use of corticosteroids for 2019-nCoV pneumonia.","volume":"395","author":"Shang","year":"2020","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"year":"2020","journal-title":"Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (Ncov) Infection is Suspected: Interim Guidance.","key":"B20"},{"year":"2022","journal-title":"Coronavirus disease (COVID-19) pandemic","key":"B21"},{"key":"B22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.","volume":"180","author":"Wu","year":"","journal-title":"JAMA Intern. Med"},{"key":"B23","article-title":"Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.","volume":"24","author":"Wu","year":"","journal-title":"Crit. Care"},{"key":"B24","first-page":"179","article-title":"[Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy].","volume":"43","author":"Xiao","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3760\/cma.j.issn.1001-0939.2020.0007","article-title":"[Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].","volume":"43","author":"Zhao","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.953328\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T07:12:10Z","timestamp":1658214730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.953328\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,19]]},"references-count":26,"alternative-id":["10.3389\/fmicb.2022.953328"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.953328","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2022,7,19]]},"article-number":"953328"}}